Life Care Center Of Merrimack Valley Medicare and Medicaid Location: 80 Boston Road, Billerica, Massachusetts 01862 Ratings: Phone: (978) 667-2166 |
News Archive
A novel partnership between Massachusetts General Hospital and Massachusetts Institute of Technology is addressing three major challenges in clinical medicine – improving the diagnosis of disease, developing new approaches to prevent and treat infectious and autoimmune diseases, and developing more accurate methods of diagnosing and treating major neurodegenerative and psychiatric diseases. While individual collaborations between MGH and MIT investigators are nothing new, this formalized strategic partnership is designed to accelerate the development of diagnostic tools and therapies.
People with HIV/tuberculosis coinfection who began antiretroviral treatment within six months of starting TB treatment had a 55% lower mortality rate than people with HIV/TB coinfection who did not begin antiretroviral therapy until after they had finished a six-month TB treatment course, according to a study conducted by researchers at the University of KwaZulu-Natal, Business Day reports (Kahn, Business Day, 9/18).
Chiasma, Inc., a privately held biopharma company, presented pharmacology results from clinical studies at the 12th International Pituitary Congress showing that Octreolin, a proprietary investigational new oral formulation of octreotide, demonstrated a consistent pharmacokinetic (PK) profile similar to that of subcutaneously injected octreotide acetate.
The Warburg Effect describes a phenomenon in which cancer cells voraciously consume glucose for energy - something scientists have long known, yet have had little success exploiting as a way to stunt tumor growth.
A new multi-site study reveals patients with drug-resistant HIV can safely achieve viral suppression - the primary goal of HIV therapy - without incorporating the traditional class of HIV medications into their treatment regimen.
› Verified 5 days ago